FFreeCE GuideContinuing education · No cost

Academy for Continued Healthcare Learning

Sustainable and Scalable Strategies for Safe and Effective Administration of Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma in Outpatient and Community Settings

Sustainable and Scalable Strategies for Safe and Effective Administration of Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma in Outpatient and Community Settings. A free accredited ACHL enduring CME/CE activity.

Available on demand4.5 CMEFree course and certificate

Before you enroll

Is this the right course for you?

Sustainable and Scalable Strategies for Safe and Effective Administration of Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma in Outpatient and Community Settings is offered by Academy for Continued Healthcare Learning for physicians. Topics in this listing: Clinical practice.

Check the credit type and approval notes below against your credential. The provider handles enrollment, completion and the certificate.

Course details

Provider
Academy for Continued Healthcare Learning
Format
On demand
Profession
Physicians
Credit expiration
Apr 10, 2027
Registration
Free provider account required
Last checked
Oct 10, 2026
Language
English

Credits & eligibility

4.5 CME

Provider-designated AMA PRA Category 1 Credit. AAPA, AANP and ANCC reciprocity is provider-stated where disclosed; verify acceptance for your credential.

Listed roles: Physician

State scope: No individual state acceptance claim is made in this listing.

ACCME

What’s free

Course access
$0
Assessment
$0
Certificate
$0
Credit reporting
$0 — no separate reporting fee identified

The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.

How to earn your credit

  1. Create an ACHL account, complete the pretest, view the online activity, and score at least 66% on the posttest.
  2. Complete the evaluation. The certificate is immediately available at no fee.

Questions about this course

Is “Sustainable and Scalable Strategies for Safe and Effective Administration of Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma in Outpatient and Community Settings” completely free?

The recorded cost is $0 for learning, assessment and the certificate, with no separate reporting fee identified. Academy for Continued Healthcare Learning requires a free account. The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.

Which credit can I earn?

The provider lists 4.5 CME. Recorded roles: Physician. Match the individual track below to your credential and board before enrolling.

When can I take this course?

This is an on-demand activity in the current collection; follow the source link to begin. The recorded credit expiration date is 2027-04-10.

What do I need to do for the certificate?

Create an ACHL account, complete the pretest, view the online activity, and score at least 66% on the posttest. Complete the evaluation. The certificate is immediately available at no fee. Completion and certificate delivery are handled by Academy for Continued Healthcare Learning; saving this listing does not enroll you or claim credit.

Sources & verification

These are the primary pages supporting this listing. Course recognition and board acceptance should be confirmed for your credential before enrollment.

Your next credential

Free exam preparation for physicians

Preparing for an exam, too? Explore free practice questions and explanations on OpenExamPrep.

OpenExamPrepFree exam preparation
Free practice

USMLE Step 1

200 practice questions Free practice

USMLE Step 2 CK

260 practice questions
Explore all 224 exams for physicians →

These are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.

Keep exploring

More for your profession
Academy for Continued Healthcare LearningFree
Available on demand

Strategies for Improving ERBB2 (HER2) Testing in NSCLC Within Community Settings

The pace at which targetable tumor-specific molecular alterations have been identified over the past decade have ushered in an era of precision oncology, yielding significant insights into the diversity of cancer, offering diagnostic and prognostic benefits, and guiding therapy selection. Indeed, guidelines emphasize that comprehensive biomarker testing should be conducted to identify actionable mutations in non-small-cell lung cancer (NSCLC), including ALK, EGFR, KRAS, MET, RET, and ERBB2 (HER2). These tests guide the selection of targeted therapies that can inhibit oncogenic pathways directl

2.5 CME + moreOn demand
Checked Oct 10, 2026
Academy for Continued Healthcare LearningFree
Available on demand

Navigating Complexity in the Post-CDK4/6 Inhibitor Treatment Setting for Patients With ER+/HER2- mBC: Strategies for Optimally Integrating Next-Generation Oral SERDs

The management of hormone receptor–positive (HR-positive), human epidermal growth factor receptor 2–negative (HER2-negative) metastatic breast cancer (mBC) is undergoing rapid transformation, largely driven by the imperative to overcome acquired endocrine resistance, frequently mediated by somatic estrogen receptor 1 (ESR1) mutations. These mutations predict a lack of benefit from further aromatase inhibitor (AI) therapy, making the correct identification and subsequent targeting of these alterations critical for guiding treatment selection. Next-generation oral selective estrogen receptor deg

2 CME + moreOn demand
Checked Oct 10, 2026
DHA J-7 Continuing Education Program OfficeFree
Starts within 7 days

Tier 4 Tactical Combat Casualty Care (TCCC) – Combat Paramedic/Provider

Location Faculty Accreditations Register OverviewIn order to avoid preventable deaths on the battlefield due to combat injuries it is essential to provide lifesaving medical interventions immediately at the point of injury within the tactical environment. The Defense Health Agency (DHA), in coordination with subject matter experts from the Joint Trauma System’s (JTS) Committee on Tactical Combat Casualty Care (CoTCCC), developed a standardized training curriculum to provide evidence-based, lifesaving techniques and strategies for combat casualty care. Tier 4 Combat Paramedic and Provider (CPP)

62 CME + moreLive webinar
Oct 12, 2026, 12:00 AM EDT